A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
about
Rome Consensus Conference - statement; human papilloma virus diseases in malesProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsHPV in oropharyngeal cancer: the basics to know in clinical practiceDisruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancerHuman papillomavirus vaccination guideline update: American Cancer Society guideline endorsementCurrent global status & impact of human papillomavirus vaccination: Implications for IndiaAnalysis of the papillomavirus E2 and bromodomain protein Brd4 interaction using bimolecular fluorescence complementationHuman papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.HPV infection and cervical disease: a review.Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.Improving Human Papillomavirus (HPV) Vaccination in the Postpartum Setting.Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 InfectionLessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma.Alternative dosage schedules with HPV virus-like particle vaccines.HPV catch-up vaccination of young women: a systematic review and meta-analysis.Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of ChinaEfficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial.Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers.Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)The distribution of high-risk human papillomaviruses is different in young and old patients with cervical cancerTwo distinct pathways to development of squamous cell carcinoma of the vulva.Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer.Human papillomavirus testing in the prevention of cervical cancerHPV knowledge and impact of genital warts on self esteem and sexual life in Colombian patients.Immune therapy for human papillomaviruses-related cancers.Human papillomavirus disease and vaccines in adolescents.Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia.Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control.Predictors of three dose on-time compliance with HPV4 vaccination in a disadvantaged, underserved, safety net population in the US Midwest.HPV - immune response to infection and vaccinationThe role of sexual behavior in head and neck cancer: implications for prevention and therapy.Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes[Efficacy of commercially available vaccines against HPV infection in women: a systematic review and meta-analysis].Human papillomavirus vaccination: current indications and future directionsThe known unknowns of HPV natural history.Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort studyCDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer
P2860
Q21257274-E54CF734-FBC3-4423-A412-EB63F093770CQ24202048-76B3648B-E880-419E-AD52-3891B24513D0Q24235373-4F4FB632-E135-4528-95FF-52AB8F611493Q26853669-C1084F2E-4D7E-4EB2-8A88-A50B9E83A5F6Q27020978-E300B4BD-8CCC-4431-97C6-EF7A65E12B9BQ28069669-233C60E5-4E35-497B-9065-0BE8F9A5AB8DQ28079776-3359A4CF-CCD8-407E-AE9D-3B8119FEB5C1Q28534628-1204D96A-5982-4B8E-BBFB-4F7DE4233A97Q30301333-B7317578-6A25-4530-8768-C9EFAEFF684DQ30354637-BF2FC115-8F90-4275-A46D-7E4373900A4AQ33159907-28C11B6F-BB77-4941-825A-B9FF7DEC17BDQ33803206-38B9BF2D-00C7-4CB4-91B3-C0E0F7A517DCQ33905003-904577A4-AA43-452B-A962-ECD28F96A814Q33907700-CFA9203A-47E5-4E86-AD8F-2E6D52678FC3Q34064235-21392278-CA0C-42EE-BFFA-817E07C9165FQ34102466-663FFDC1-27E6-4E3F-8C50-492782129301Q34157209-A1E03F42-73B0-4414-A493-3665DCA0C245Q34182283-74B5E649-6D96-4405-B4CA-29F07A14067EQ34199560-09BB63B3-64EE-443B-AEE3-D5D86880031AQ34206463-899A79C8-21E4-4202-BD06-A2F5D4D48805Q34286142-B3A7B89A-0AA5-4C5A-B06B-5A68A4BCEF86Q34308427-3E598CDF-092D-49BC-9A9C-312D2FB47E39Q34415184-1F1BD71C-B95C-4D88-8911-01AE6678D9F2Q34584632-1846DFBD-D5B3-4005-9112-F4C6D2042D5FQ34616083-7B6837FC-452C-4274-9CDB-C5E6A6F3C6A4Q34636357-FD06344A-265C-4607-AFFF-1CD9C0088637Q34657561-19F50F58-30ED-4E7B-9856-6BFEF18F7B21Q34675079-50B2D000-FF69-43BA-BA31-91304C7BCD2EQ34743370-E031F065-AD10-4779-9507-273A33ADE99EQ34790522-6DF255EA-41B4-4AD6-B467-D079F868B4BBQ34866621-D8EA6C0E-343E-4088-8559-4543EE1F6DA4Q34949073-B8F3AF7A-25A1-48CF-8874-5743CB1180A5Q35180148-4F7AC8DD-C04C-4445-B5EE-CDB023653088Q35272050-CEF048D6-B6DD-4D62-874C-B069792CAFDEQ35273321-05F710D6-6CB3-4D85-8E32-D51D5A180AC4Q35427518-FA3E0961-BF05-4ADC-BAFA-D7D01B329B5EQ35558593-52051C53-D713-4D37-B64F-E8B5019C7F89Q35578583-FDC115A5-9900-4877-B1D6-827EAD25BBE7Q35596225-02845CE7-6FF8-443C-AB50-31073AE1B8E3Q35776083-2F171102-8B8C-43B5-8EBD-8E7A2B68B62D
P2860
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
description
article
@en
im September 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2009
@uk
name
A Pooled Analysis of Continued ...... l and External Genital Lesions
@en
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus
@nl
type
label
A Pooled Analysis of Continued ...... l and External Genital Lesions
@en
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus
@nl
prefLabel
A Pooled Analysis of Continued ...... l and External Genital Lesions
@en
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus
@nl
P2093
P50
P1476
A pooled analysis of continued ...... l and external genital lesions
@en
P2093
Alfred Saah
Amha Tadesse
Daron G Ferris
Darron R Brown
Eliav Barr
Elmar A Joura
Eng Hseon Tay
Evan R Myers
F Xavier Bosch
Frank J Taddeo
P304
P356
10.1158/1940-6207.CAPR-09-0031
P577
2009-09-29T00:00:00Z